Location: Atlanta
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Atlanta
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Phase 3 · Investigative Site US061 · Incyte Corporation · NCT06959225The PREDICT Registry:
Phase N/A · Emory University Winship Cancer Institute · PreludeDx · NCT03448926Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Phase 1 · Emory University School of Medicine · USWM CT, LLC · NCT03391778A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants
Phase 3 · Randomize Now, LLC · Hoffmann-La Roche · NCT06588855Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable
Phase 2 · Emory University Hospital/Winship Cancer Institute · Emory University · NCT06423326Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · Emory University · Corvus Pharmaceuticals, Inc. · NCT06561048Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06961968A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · Children's Healthcare Atlanta · Novo Nordisk A/S · NCT06612268A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · Northside Hosptal · New York Blood Center · NCT01656603Parent-Mediated Telehealth Intervention for Insomnia in Young Autistic Children
NA · Emory School Of Medicine · Emory University · NCT07435740Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in
Phase 2 · AbbVie · NCT06846320Botulinum Toxin in Raynaud's Phenomenon
Phase 4 · Emory University Hospital · Emory University · NCT05125029NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants W
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06911112A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Phase 4 · CenExel · ModernaTX, Inc. · NCT06585241Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · Global Research Associates /ID# 234646 · AbbVie · NCT03339128NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · Children's Healthcare of Atlanta · St. Jude Children's Research Hospital · NCT06239272Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · Emory University Hospital Midtown · National Cancer Institute (NCI) · NCT06029270A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard
Phase N/A · Emory Healthcare, Emory Clinic · Regeneron Pharmaceuticals · NCT06693531Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · Emory University School of Medicine · Jaeb Center for Health Research · NCT06837181Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · Children's Healthcare of Atlanta · Fred Hutchinson Cancer Center · NCT03779854ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
NA · Emory University Hospital · JenaValve Technology, Inc. · NCT06608823A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment
Phase 1 · Emory University · Servier Bio-Innovation LLC · NCT07006688Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Grady Health System · National Cancer Institute (NCI) · NCT05987241Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Phase 4 · Emory University Hospital · Fresenius Kabi · NCT06049680Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Piedmont Cancer Institute · Gilead Sciences · NCT05633654A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06256588Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
NA · Grady Health System · Emory University · NCT06932588A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin)
Phase 1/Phase 2 · Winship Cancer Institute · Eisai Inc. · NCT04300556MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Grady Health System · Stryker Instruments · NCT03072927
Look up another city
Look up another condition